Personal Genome Diagnostics (PGDx) is a biotechnology company specializing in cancer genomics and molecular diagnostics. Founded by researchers from Johns Hopkins University, PGDx is dedicated to developing advanced technologies for genomic analyses to enhance cancer diagnosis and treatment. The company offers comprehensive genomic testing services and products, including proprietary technologies for identifying and understanding the genetic alterations associated with various cancer types. Their solutions are designed to support oncology research and guide personalized treatment plans, leveraging genomic data to provide insights into cancer mutations and patient-specific tumor profiling.